Pasar al contenido principal

IDENTIFICACION DE ESTRATEGIAS DE INTERVENCION BASADAS EN EL MICROBIOMA INTESTINAL PARA REDUCIR EL RIESGO DE DESARROLLAR OBESIDAD, DEPRESION Y SUS COMORBILIDADES

AGL2017-88801-P

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening

  • Benítez-Páez, Alfonso
  • Gómez del Pulgar, Eva M.
  • López-Almela, Inmaculada
  • Moya Pérez, Ángela
  • Codoñer-Franch, Pilar
  • Sanz Herranz, Yolanda
Cross-sectional studies conducted with obese and control subjects have suggested associations between gut microbiota alterations and obesity, but the links with specific disease phenotypes and proofs of causality are still scarce. The present study aimed to profile the gut microbiota of lean and obese children with and without insulin resistance to characterize associations with specific obesity-related complications and understand the role played in metabolic inflammation. Through massive sequencing of 16S rRNA gene amplicons and data analysis using a novel permutation approach, we have detected decreased incidence of Blautia species, especially Blautia luti and B. wexlerae, in the gut microbiota of obese children, which was even more pronounced in cases with both obesity and insulin resistance. There was also a parallel increase in proinflammatory cytokines and chemokines (gamma interferon [IFN-γ], tumor necrosis factor alpha [TNF-α], and monocyte chemoattractant protein 1 [MCP-1]) in feces of obese children compared to those of lean ones. B. luti and B. wexlerae were also shown to exert an anti-inflammatory effect in peripheral blood mononuclear cell cultures in vitro, compared to non-obesity-associated species. We suggest that the depletion of B. luti and B. wexlerae species in the gut ecosystem may occur in cases of obesity and contribute to metabolic inflammation leading to insulin resistance., This study was supported by grant AGL2017-88801-P from the Ministry of Science, Innovation and Universities (MCIU; Spain) and the European Union’s Seventh Framework Program under grant agreement no. 613979 (MyNewGut). The contracts of A.B.-P. and E.M.G.D.P. were supported by the MyNewGut project. The FPI grant for I.L.-A. from MCIU (Spain) is fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet

  • González-Ramos, Silvia
  • Paz-García, Marta
  • Fernández-García, Victoria
  • Portune, Kevin J.
  • Acosta Medina, Emilio F.
  • Sanz Herranz, Yolanda
  • Castrillo, Antonio
  • Martín-Sanz, Paloma
  • Obregón, María Jesús
  • Boscá, Lisardo
The contribution of the nucleotide-binding oligomerization domain protein NOD1 to obesity has been investigated in mice fed a high fat diet (HFD). Absence of NOD1 accelerates obesity as early as 2 weeks after feeding a HFD. The obesity was due to increases in abdominal and inguinal adipose tissues. Analysis of the resting energy expenditure showed an impaired function in NOD1-deficient animals, compatible with an alteration in thyroid hormone homeostasis. Interestingly, free thyroidal T4 increased in NOD1-deficient mice fed a HFD and the expression levels of UCP1 in brown adipose tissue were significantly lower in NOD1-deficient mice than in the wild type animals eating a HFD, thus contributing to the observed adiposity in NOD1-deficient mice. Feeding a HFD resulted in an alteration of the proinflammatory profile of these animals, with an increase in the infiltration of inflammatory cells in the liver and in the white adipose tissue, and an elevation of the circulating levels of TNF-α. In addition, alterations in the gut microbiota in NOD1-deficient mice correlate with increased vulnerability of their ecosystem to the HFD challenge and affect the immune-metabolic phenotype of obese mice. Together, the data are compatible with a protective function of NOD1 against low-grade inflammation and obesity under nutritional conditions enriched in saturated lipids. Moreover, one of the key players of this early obesity onset is a dysregulation in the metabolism and release of thyroid hormones leading to reduced energy expenditure, which represents a new role for these hormones in the metabolic actions controlled by NOD1., This work was supported by Grants SAF2017-82436R, AGL2017-88801-P and SAF2016-75004R from MINECO/AEI/FEDER/EU, S2017/BMD-3686 from Comunidad de Madrid, CIVP18A3864 from Fundación Ramón Areces and CIBERCV and CIBERHED (funded by the Instituto de Salud Carlos III) and Fondos FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Breast-Milk Microbiota Linked to Celiac Disease Development in Children: A Pilot Study From the PreventCD Cohort

  • Benítez-Páez, Alfonso
  • Olivares, Marta
  • Szajewska, H.
  • Pieścik-Lech, M.
  • Polanco, I.
  • Castillejo, G.
  • Nuñez, Merce
  • Ribes-Koninckx, Carmen
  • Korponay-Szabó, I. R.
  • Koletzko, S.
  • Meijer, C. R
  • Mearin, M. L.
  • Sanz Herranz, Yolanda
Celiac disease (CeD) is an immune-mediated disorder triggered by exposure to dietary gluten proteins in genetically predisposed individuals. In addition to the host genome, the microbiome has recently been linked to CeD risk and pathogenesis. To progress in our understanding of the role of breast milk microbiota profiles in CeD, we have analyzed samples from a sub-set of mothers (n = 49) included in the PreventCD project, whose children did or did not develop CeD. The results of the microbiota data analysis indicated that neither the BMI, HLA-DQ genotype, the CeD condition nor the gluten-free diet of the mothers could explain the human milk microbiota profiles. Nevertheless, we found that origin country, the offspring’s birth date and, consequently, the milk sampling date influenced the abundance and prevalence of microbes in human milk, undergoing a transition from an anaerobic to a more aerobic microbiota, including potential pathogenic species. Furthermore, certain microbial species were more abundant in milk samples from mothers whose children went on to develop CeD compared to those that remained healthy. These included increases in facultative methylotrophs such as Methylobacterium komagatae and Methylocapsa palsarum as well as in species such as Bacteroides vulgatus, that consumes fucosylated-oligosaccharides present in human milk, and other breast-abscess associated species. Theoretically, these microbiota components could be vertically transmitted from mothers-to-infants during breastfeeding, thereby influencing CeD risk., This work was supported by grant AGL2017-88801-P from Ministerio de Ciencia, Innovación y Universidades (MCIU, Spain). The postdoctoral contract of Marta Olivares from “Juan de la Cierva” program (MCIU, Spain) is fully acknowledged. PreventCD consortium is supported by grants from the European Commission (FP6-2005-FOOD-4B-36383–PREVENTCD), the Azrieli Foundation, Deutsche Zöliakie Gesellschaft, Eurospital, Fondazione Celiachia, Fria Bröd, Instituto de Salud Carlos III, Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Komitet Badañ Naukowych (1715/B/P01/2008/34), Fundacja Nutricia (1W44/FNUT3/2013), Hungarian Scientific Research Funds (OTKA101788 and TAMOP 2.2.11/1/KONV-20 12-0023), Stichting Coeliakie Onderzoek Nederland (STICOON), Thermo Fisher Scientific, and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteroides uniformis CECT 7771 alleviates inflammation within the gut-adipose tissue axis involving TLR5 signaling in obese mice

  • Fabersani, Emanuel
  • Portune, Kevin
  • Campillo, Isabel
  • López-Almela, Inmaculada
  • Montserrat-de la Paz, Sergio
  • Romaní Pérez, Marina
  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
This study investigated the immune mechanisms whereby administration of Bacteroides uniformis CECT 7771 reduces metabolic dysfunction in obesity. C57BL/6 adult male mice were fed a standard diet or a Western diet high in fat and fructose, supplemented or not with B. uniformis CECT 7771 for 14 weeks. B. uniformis CECT 7771 reduced body weight gain, plasma cholesterol, triglyceride, glucose, and leptin levels; and improved oral glucose tolerance in obese mice. Moreover, B. uniformis CECT 7771 modulated the gut microbiota and immune alterations associated with obesity, increasing Tregs and reducing B cells, total macrophages and the M1/M2 ratio in both the gut and epididymal adipose tissue (EAT) of obese mice. B. uniformis CECT 7771 also increased the concentration of the anti-inflammatory cytokine IL-10 in the gut, EAT and peripheral blood, and protective cytokines TSLP and IL-33, involved in Treg induction and type 2 innate lymphoid cells activation, in the EAT. It also restored the obesity–reduced TLR5 expression in the ileum and EAT. The findings indicate that the administration of a human intestinal bacterium with immunoregulatory properties on the intestinal mucosa helps reverse the immuno-metabolic dysfunction caused by a Western diet acting over the gut-adipose tissue axis., This work is supported by the European Union’s Seventh Framework Program under the Grant Agreement No 613979 (MyNewGut) and Grant AGL2017-88801-P from the Spanish Ministry of Science and Innovation (MICINN, Spain). The Santiago Grisolía scholarship (GRISOLIAP/2014/110) to E.F from Generalitat Valenciana and the FPI scholarship (BES-2015-073930) of I López-Almela and the PTA contract (PTA2013-8836-I) of I. Campillo from MICINN are fully acknowledged. The authors declare that there are no competing interests in this research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis

  • Romaní Pérez, Marina
  • Bullich Vilarrubias, Clara
  • López-Almela, Inmaculada
  • Liébana García, Rebeca
  • Olivares Sevilla, Alicia
  • Sanz Herranz, Yolanda
Obesity currently represents a major societal and health challenge worldwide. Its prevalence has reached epidemic proportions and trends continue to rise, reflecting the need for more effective preventive measures. Hypothalamic circuits that control energy homeostasis in response to food intake are interesting targets for body-weight management, for example, through interventions that reinforce the gut-to-brain nutrient signalling, whose malfunction contributes to obesity. Gut microbiota–diet interactions might interfere in nutrient sensing and signalling from the gut to the brain, where the information is processed to control energy homeostasis. This gut microbiota–brain crosstalk is mediated by metabolites, mainly short chain fatty acids, secondary bile acids or amino acids-derived metabolites and subcellular bacterial components. These activate gut–endocrine and/or neural-mediated pathways or pass to systemic circulation and then reach the brain. Feeding time and dietary composition are the main drivers of the gut microbiota structure and function. Therefore, aberrant feeding patterns or unhealthy diets might alter gut microbiota–diet interactions and modify nutrient availability and/or microbial ligands transmitting information from the gut to the brain in response to food intake, thus impairing energy homeostasis. Herein, we update the scientific evidence supporting that gut microbiota is a source of novel dietary and non-dietary biological products that may beneficially regulate gut-to-brain communication and, thus, improve metabolic health. Additionally, we evaluate how the feeding time and dietary composition modulate the gut microbiota and, thereby, the intraluminal availability of these biological products with potential effects on energy homeostasis. The review also identifies knowledge gaps and the advances required to clinically apply microbiome-based strategies to improve the gut–brain axis function and, thus, combat obesity., This work is supported by grant AGL2017-88801-P from the Spanish Ministry of Science and Innovation (MICINN, Spain). The Marie Sklodowska-Curie grant agreement No. 797297 (M.R-P), the FPI grant of I.L.-A., the FPU grant of R.L. and the Juan de la Cierva contract of M.O. and the contract of C. B-V for promotion of youth employment in R+D+I from MICINN (Spain) are fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice

  • Romaní Pérez, Marina
  • López-Almela, Inmaculada
  • Bullich Vilarrubias, Clara
  • Rueda-Ruzafa, Lola
  • Gómez del Pulgar, Eva M.
  • Benítez-Páez, Alfonso
  • Liebisch,Gerhard
  • Lamas, José Antonio
  • Sanz Herranz, Yolanda
Impaired glucose homeostasis in obesity is mitigated by enhancing the glucoregulatory actions of glucagon-like peptide 1 (GLP-1), and thus, strategies that improve GLP-1 sensitivity and secretion have therapeutic potential for the treatment of type 2 diabetes. This study shows that Holdemanella biformis, isolated from the feces of a metabolically healthy volunteer, ameliorates hyperglycemia, improves oral glucose tolerance and restores gluconeogenesis and insulin signaling in the liver of obese mice. These effects were associated with the ability of H. biformis to restore GLP-1 levels, enhancing GLP-1 neural signaling in the proximal and distal small intestine and GLP-1 sensitivity of vagal sensory neurons, and to modify the cecal abundance of unsaturated fatty acids and the bacterial species associated with metabolic health. Our findings overall suggest the potential use of H biformis in the management of type 2 diabetes in obesity to optimize the sensitivity and function of the GLP-1 system, through direct and indirect mechanisms., This study received funding from the European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 797297 (M.R-P), from the European Union 7th Framework Program through the MyNewGut project (Grant agreement No. 613979) and from the Spanish Ministry of Science and Innovation (MICINN, Spain) (Grant AGL2017-88801-P). The FPI grant of I.L-A from the Ministry of Science and Innovation (MICINN; Spain) and the contract of C. B-V for promotion of youth employment in R+D+I from MICINN (Spain) are fully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome

  • Hillestad, Eline Margrete Randulff
  • van der Meeren, Aina
  • Nagaraja, Bharat Halandur
  • Bjørsvik, Ben René
  • Haleem, Noman
  • Benítez-Páez, Alfonso
  • Sanz Herranz, Yolanda
  • Hausken, Trygve
  • Lied, Gülen Arslan
  • Lundervold, Arvid
  • Berentsen, Birgitte
Irritable bowel syndrome (IBS) is a common clinical label for medically unexplained gastrointestinal symptoms, recently described as a disturbance of the microbiota-gut-brain axis. Despite decades of research, the pathophysiology of this highly heterogeneous disorder remains elusive. However, a dramatic change in the understanding of the underlying pathophysiological mechanisms surfaced when the importance of gut microbiota protruded the scientific picture. Are we getting any closer to understanding IBS' etiology, or are we drowning in unspecific, conflicting data because we possess limited tools to unravel the cluster of secrets our gut microbiota is concealing? In this comprehensive review we are discussing some of the major important features of IBS and their interaction with gut microbiota, clinical microbiota-altering treatment such as the low FODMAP diet and fecal microbiota transplantation, neuroimaging and methods in microbiota analyses, and current and future challenges with big data analysis in IBS., Supported by the Spanish Ministry of Science and Innovation (MICINN, Spain), No. AGL2017-88801-P (to Sanz Y); the Miguel Server grant from the Spanish "Carlos III" Health Institute (ISCIII), No. CP19/00132 (to Benitez-Paez A); The Norwegian Research Council (Funding Post-doc Position for Bharath Halandur Nagaraja), No. FRIMEDBIO276010; and Helse Vest’s Research Funding, No. HV912243; and ERC H2020-MSCA-IF-2019, No. 895219 (to Haleem N)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease

  • López Siles, Mireia
  • Camprubí Font, Carla
  • Gómez del Pulgar, Eva M.
  • Sabat Mir, Miriam
  • Busquets, David
  • Sanz Herranz, Yolanda
  • Martínez Medina, Margarita
Adherent-invasive E. coli (AIEC) has largely been implicated in the pathogenesis of Crohn's disease (CD). E. coli strains with similar genetic backgrounds and virulence genes profiles have been associated with other intestinal disorders, such as ulcerative colitis (UC), colorectal cancer (CRC), and coeliac disease (CeD), but the role of AIEC in these diseases remains unexplored. We aimed to assess the distribution, abundance, and pathogenic features of AIEC in UC, CRC, and CeD., This work was funded by the Spanish Ministry of Education and Science through projects SAF2010-15896, SAF2013-43284-P, and SAF2107-82261-P (MINECO/AEI/FEDER/UE) and the grant AGL2017-88801-P from the Spanish Ministry of Science and Innovation (MICINN, Spain). MLS is a Serra Húnter Fellow., Peer reviewed, SAF2010-15896, SAF2013-43284-P, and SAF2107-82261-P (MINECO/AEI/FEDER/UE) and the grant AGL2017-88801-P
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat

  • Agustí, Ana
  • Campillo, Isabel
  • Balzano, Tiziano
  • Benítez-Páez, Alfonso
  • López-Almela, Inmaculada
  • Romaní Pérez, Marina
  • Forteza, Jerónimo
  • Felipo, Vicente
  • Avena, Nicole M
  • Sanz Herranz, Yolanda
Food addiction (FA) is characterized by behavioral and neurochemical changes linked to loss of food intake control. Gut microbiota may influence appetite and food intake via endocrine and neural routes. The gut microbiota is known to impact homeostatic energy mechanisms, but its role in regulating the reward system is less certain. We show that the administration of Bacteroides uniformis CECT 7771 (B. uniformis) in a rat FA model impacts on the brain reward response, ameliorating binge eating and decreasing anxiety-like behavior. These effects are mediated, at least in part, by changes in the levels of dopamine, serotonin, and noradrenaline in the nucleus accumbens and in the expression of dopamine D1 and D2 receptors in the prefrontal cortex and intestine. B. uniformis reverses the fasting-induced microbiota changes and increases the abundance of species linked to healthy metabolotypes. Our data indicate that microbiota-based interventions might help to control compulsive overeating by modulating the reward response., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants AGL2014-52101-P and AGL2017-88801-P from the Ministry of Science, Innovation and Universities (MCIU, Spain) and by grant PROMETEO/2019/015 from “Conselleria de Educación, Investigación, Cultura y Deporte” (Generalitat Valenciana, Spain). The contracts of ABP are also supported by grant AGL2017-88801-P. The pre-doctoral contract (FPI) of ILA and the technician contract (PTA) of IC from MCIU (Spain) are also fully acknowledged., Peer reviewed